Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
nference logo — Making biomedical knowledge computable

nference

Making biomedical knowledge computable

Founded 2013 United States Cambridge, United States 313 employees Non Equity Assistance Total: $152.74M Biotechnology, Health Care +1

General Information

Company Name nference
Founded Year 2013
Location United States Cambridge, United States +4
Founders / Decision Makers
Team member
Employees 313
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Non Equity Assistance
Social

Get notified when nference moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

New Partnership Sep 02, 2026

nference has announced a long-term strategic partnership with Rush University System for Health to advance AI-enabled clinical research and patient care.

Major Customer Win Sep 02, 2026

nference has gained an unnamed customer whose researchers will utilize the collaboration to uncover insights from patient data.

Get alerts when nference shows new signals

AI Insight

Bounce Watch AI
2 months ago

nference is accelerating its market position through significant expansion, now boasting a federated EHR system encompassing over 29 million patients. Leveraging this extensive dataset, the company recently launched MAIA, a new AI platform specifically for cardiometabolic medicine, demonstrating a strategic move into new therapeutic areas. This product innovation, alongside active thought leadership in AI, underscores their commitment to data-driven therapeutic advancement.

Signal Types
Traction Event Hiring Product Launch
Strategic Labels
AI Innovation Market Expansion Product Diversification
Next Move: Fundraising
·
Impact: 9/10
·
Ideal For: HealthTech VCs — Growth Stage, AI/Biotech Investors

About nference

nference, founded in 2013, is driving innovation in the Biotechnology, Health Care, and Life Sciences sectors. Headquartered in the United States, nference specializes in transforming biomedical knowledge into computable insights, which aids in accelerating drug development, generating evidence, and improving clinical trials.

The company leverages its network of top academic minds and world-class researchers in conjunction with real-time, multimodal, patient-level data. Their flagship platform, nSights, delivers unparalleled biological and clinical insights to enhance patient care.

nference's last recorded investment was a Non Equity Assistance on 08 December 2022, with backing from PharmStars. Investors may find the company's advanced analytical capabilities and partnerships with leading researchers appealing, especially in an era increasingly reliant on data-driven healthcare solutions.

Taxonomy: Biomedical Knowledge Computation, Drug Development Innovation, Clinical Trial Optimization, Multimodal Patient Data, Real-time Data Analysis, Personalized Medicine, Biological Insights, Clinical Insights, EMR Data Transformation, Biopharmaceutical Solutions, Patient-Centric Care, Academic Collaboration, Healthcare Ecosystem Integration, Evidence Generation

Services & Products

AI-powered clinical data analysis
Patient cohort design
Data annotation for model development
Advanced data science workbench
Translational science for ECG decoding

Target Customers

Clinical researchers Healthcare providers Pathology labs Medical centers Pharmaceutical companies

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance •••••• 1
Investor
08 Dec 2022
Venture Round •••••• - 04 Nov 2022
Venture Round •••••• 1 •••• •••• 16 Jan 2021
Series C •••••• 4
Investor Investor Investor Investor
15 Dec 2020
Series B •••••• 4
Investor Investor Investor Investor
08 Jan 2020

View All 7 Funding Rounds

nference Alternatives & Competitors

nference vs
VidiStar
VidiStar

Experience seamless remote diagnostic interpretation and advanced patient data insights for enhanced...

Biotechnology, Health Care
nference vs
ClinOne
ClinOne United States

The results you need. The experience patients deserve. Technology to connect, inform and empower cli...

Series A
14 employees
Health Care
Compare nference vs ClinOne
nference vs
physIQ
physIQ United States

physIQ delivers personalized medical predictions that vastly improve patient outcomes.

Grant
18 employees
Analytics, Hardware
Compare nference vs physIQ
Also compare with: nference vs Humedica Humedica

FAQ About nference

Making biomedical knowledge computable
nference was founded in 2013.
nference is headquartered in Cambridge, United States.
nference operates in the following industries: Biotechnology, Health Care, Life Sciences.
nference has approximately 313 employees.
nference has completed 7 funding rounds, raising a total of $152.74M. The latest funding stage is Non Equity Assistance.
nference offers: AI-powered clinical data analysis, Patient cohort design, Data annotation for model development, Advanced data science workbench, Translational science for ECG decoding.
Top alternatives and competitors to nference include VidiStar, ClinOne, physIQ, Humedica, Continuum Clinical, A Spectrum Science Company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
nference and VidiStar are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors nference and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy